Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Cellebrite DI Ltd (NASDAQ: CLBT) closed the day trading at $16.36 down -0.24% from the previous closing price of $16.4. In other words, the price has decreased by -$0.24 from its previous closing price. On the day, 1.6 million shares were traded. CLBT stock price reached its highest trading level at $16.4 during the session, while it also had its lowest trading level at $16.08.
Ratios:
For a better understanding of CLBT, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.30 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.10. For the most recent quarter (mrq), Quick Ratio is recorded 1.90 and its Current Ratio is at 1.93. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on March 28, 2024, Reiterated its Buy rating but revised its target price to $13.50 from $13 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 02 ’25 when Aliazar Keinan bought 6,847 shares for $16.36 per share.
ZOHAR TADMOR bought 44,623 shares of CLBT for $722,768 on Aug 27 ’25. On Aug 26 ’25, another insider, ZOHAR TADMOR, who serves as the Officer of the company, bought 10,281 shares for $16.02 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLBT now has a Market Capitalization of 3999512832 and an Enterprise Value of 3549661696. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.97 while its Price-to-Book (P/B) ratio in mrq is 9.59. Its current Enterprise Value per Revenue stands at 8.128 whereas that against EBITDA is 47.627.
Stock Price History:
The Beta on a monthly basis for CLBT is 1.28, which has changed by -0.028503537 over the last 52 weeks, in comparison to a change of 0.16222072 over the same period for the S&P500. Over the past 52 weeks, CLBT has reached a high of $26.30, while it has fallen to a 52-week low of $13.10. The 50-Day Moving Average of the stock is 8.91%, while the 200-Day Moving Average is calculated to be -11.85%.
Shares Statistics:
Over the past 3-months, CLBT traded about 1.81M shares per day on average, while over the past 10 days, CLBT traded about 1806640 shares per day. A total of 239.47M shares are outstanding, with a floating share count of 108.89M. Insiders hold about 54.53% of the company’s shares, while institutions hold 39.90% stake in the company. Shares short for CLBT as of 1755216000 were 5160766 with a Short Ratio of 2.86, compared to 1752537600 on 3357008. Therefore, it implies a Short% of Shares Outstanding of 5160766 and a Short% of Float of 4.2700000000000005.
